Testing effectiveness (Phase 2)Active Not RecruitingNCT03693014
What this trial is testing
Several Radiation Doses for Patients With Progression on Immunotherapy/Checkpoint Inhibitors
Who this might be right for
Metastatic CancerMelanoma CancerLung Cancer+3 more
Memorial Sloan Kettering Cancer Center 69